Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.17 USD | +1.15% | +4.00% | +8.56% |
03-20 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
03-20 | Sector Update: Health Care Stocks Down Wednesday Afternoon | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company is in a robust financial situation considering its net cash and margin position.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Sales forecast by analysts have been recently revised upwards.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 45.99 times its estimated earnings per share for the ongoing year.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.56% | 3.01B | B- | ||
-2.54% | 187B | C+ | ||
-1.85% | 106B | C | ||
-4.26% | 66.9B | A | ||
+1.39% | 49.45B | B- | ||
+16.82% | 48B | B- | ||
+4.06% | 40.84B | B+ | ||
+3.49% | 26.48B | B | ||
+0.65% | 26.25B | A- | ||
+12.96% | 24.62B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LIVN Stock
- Ratings LivaNova PLC